LCM
TMO icon

Liberty Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Liberty Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.52M Buy
+17,002
New +$8.16M 1.47% 19
2025
Q4 		$9.82M Hold
16,951
– – 1.83% 12
2025
Q3 		$8.22M Buy
16,951
+359
+2% +$167K 1.55% 19
2025
Q2 		$6.73M Buy
16,592
+46
+0.3% +$19.2K 1.36% 22
2025
Q1 		$8.23M Sell
16,546
-80
-0.5% -$43.3K 1.83% 15
2024
Q4 		$8.65M Buy
16,626
+30
+0.2% +$16.5K 1.92% 13
2024
Q3 		$10.3M Sell
16,596
-22
-0.1% -$13K 2.27% 8
2024
Q2 		$9.19M Sell
16,618
-17
-0.1% -$9.74K 2.18% 9
2024
Q1 		$9.67M Sell
16,635
-335
-2% -$188K 2.38% 9
2023
Q4 		$9.01M Sell
16,970
-342
-2% -$166K 2.36% 8
2023
Q3 		$8.76M Buy
17,312
+160
+0.9% +$85.3K 2.59% 5
2023
Q2 		$8.95M Buy
17,152
+66
+0.4% +$35.6K 2.68% 6
2023
Q1 		$9.85M Sell
17,086
-49
-0.3% -$27.6K 3.24% 4
2022
Q4 		$9.44M Sell
17,135
-361
-2% -$191K 3.27% 3
2022
Q3 		$8.87M Sell
17,496
-123
-0.7% -$68.8K 3.32% 5
2022
Q2 		$9.57M Sell
17,619
-431
-2% -$237K 3.41% 3
2022
Q1 		$10.7M Sell
18,050
-210
-1% -$121K 3.11% 7
2021
Q4 		$12.2M Sell
18,260
-597
-3% -$373K 3.29% 5
2021
Q3 		$10.8M Sell
18,857
-9
-0% -$4.94K 3.17% 6
2021
Q2 		$9.52M Sell
18,866
-76
-0.4% -$35.9K 2.89% 6
2021
Q1 		$8.64M Sell
18,942
-239
-1% -$114K 2.98% 5
2020
Q4 		$8.93M Buy
+19,181
New +$8.99M 3.24% 4
2020
Q2 		$6.97M Sell
19,248
-1,064
-5% -$357K 3.02% 7
2020
Q1 		$5.76M Sell
20,312
-83
-0.4% -$26.2K 3.01% 9
2019
Q4 		$6.63M Buy
20,395
+269
+1% +$81.6K 2.73% 7
2019
Q3 		$5.86M Buy
20,126
+66
+0.3% +$18.9K 2.58% 10
2019
Q2 		$5.89M Buy
20,060
+520
+3% +$143K 2.64% 7
2019
Q1 		$5.35M Sell
19,540
-10
-0.1% -$2.49K 2.7% 7
2018
Q4 		$4.38M Hold
19,550
– – 2.69% 8
2018
Q3 		$4.77M Buy
19,550
+172
+0.9% +$39.6K 2.49% 9
2018
Q2 		$4.01M Buy
19,378
+130
+0.7% +$27.6K 2.35% 10
2018
Q1 		$3.97M Sell
19,248
-221
-1% -$46.4K 2.4% 9
2017
Q4 		$4.09M Sell
19,469
-110
-0.6% -$21.1K 2.16% 10
2017
Q3 		$3.79M Buy
19,579
+411
+2% +$74.4K 2.08% 10
2017
Q2 		$3.42M Buy
19,168
+202
+1% +$33.9K 2.08% 11
2017
Q1 		$2.91M Sell
18,966
-655
-3% -$100K 1.75% 17
2016
Q4 		$2.84M Sell
19,621
-215
-1% -$31.7K 1.84% 18
2016
Q3 		$3.12M Buy
19,836
+52
+0.3% +$8.01K 2.03% 12
2016
Q2 		$2.92M Buy
19,784
+2,196
+12% +$324K 1.97% 15
2016
Q1 		$2.49M Sell
17,588
-225
-1% -$30.2K 1.87% 18
2015
Q4 		$2.53M Sell
17,813
-270
-1% -$36K 1.91% 18
2015
Q3 		$2.21M Buy
18,083
+3,060
+20% +$399K 1.74% 19
2015
Q2 		$1.95M Buy
15,023
+320
+2% +$41.7K 1.31% 30
2015
Q1 		$1.98M Buy
14,703
+5,915
+67% +$763K 1.32% 30
2014
Q4 		$1.1M Buy
8,788
+2,000
+29% +$243K 0.77% 53
2014
Q3 		$826K Buy
6,788
+500
+8% +$60.8K 0.6% 62
2014
Q2 		$742K Buy
+6,288
New +$740K 0.52% 65

Other funds holding TMO

Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

Liberty Capital Management's TMO Position: Q2 2026 in Review

Liberty Capital Management opened a new position in Thermo Fisher Scientific (TMO) in Q2 2026: 17,002 shares worth $8.52M. The stake represents 1.47% of the portfolio and ranks #19 among its holdings. This is a return to the name: Liberty Capital Management previously reported a position in TMO as recently as Q4 2025.

Liberty Capital Management first reported a position in TMO in Q2 2014 and has held it in 47 quarters since. The position peaked at $12.2M in Q4 2021. 1,172 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Liberty Capital Management held 17,002 shares of Thermo Fisher Scientific worth $8.52M as of Q2 2026.
  • Thermo Fisher Scientific was a new Liberty Capital Management position in Q2 2026.
  • Thermo Fisher Scientific made up 1.47% of Liberty Capital Management's portfolio in Q2 2026, its #19 holding.
  • Liberty Capital Management first reported a position in Thermo Fisher Scientific in Q2 2014 and has held it in 47 quarters since.
  • Liberty Capital Management's Thermo Fisher Scientific position peaked at $12.2M in Q4 2021.
  • 1,172 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Liberty Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.